AstraZeneca's trial illnesses may not be due to coronavirus shot says Oxford UniversityChristian Fernsby ▼ | September 17, 2020
The adverse events that led to a pause in trials evaluating AstraZeneca's coronavirus vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.
Trial illnesses AstraZeneca
Topics: AstraZeneca Oxford University
“After independent review, these illnesses were either considered unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine,” the document said. ■